000 01474 a2200409 4500
005 20250515055950.0
264 0 _c20070703
008 200707s 0 0 eng d
022 _a1462-0324
024 7 _a10.1093/rheumatology/kel448
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTerzioglu, E
245 0 0 _aConcurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cMay 2007
300 _a783-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aArthritis, Rheumatoid
_xmetabolism
650 0 4 _aCell Death
650 0 4 _aCells, Cultured
650 0 4 _aDown-Regulation
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
650 0 4 _aHumans
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aReceptors, TNF-Related Apoptosis-Inducing Ligand
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
_xmethods
650 0 4 _aSynovial Membrane
_xpathology
650 0 4 _aTransduction, Genetic
700 1 _aBisgin, A
700 1 _aSanlioglu, A D
700 1 _aUlker, M
700 1 _aYazisiz, V
700 1 _aTuzuner, S
700 1 _aSanlioglu, S
773 0 _tRheumatology (Oxford, England)
_gvol. 46
_gno. 5
_gp. 783-9
856 4 0 _uhttps://doi.org/10.1093/rheumatology/kel448
_zAvailable from publisher's website
999 _c16868799
_d16868799